Company profile
Trading name | NARD Institute, Ltd. |
---|---|
Locations | Headquarters: 2-6-1 Nishinagasu-cho, Amagasaki City, Hyogo Prefecture 660-0805, Japan TEL.+81-6-6482-7010 FAX.+81-6-6482-8020 |
Kobe Research Laboratory: 5-4-1 Minatojima Minamimachi, Chuo-ku, Kobe City, Hyogo Prefecture 650-004, Japan +81-78-958-7011 FAX.+81-78-958-8021 |
|
Executives | Yukio Dohi, President and CEO |
Akihiko Kawasaki, Chief Operating Officer | |
Isao Hirota, Director Yuzo Ogawa, Director |
|
Mitsuhiro Asakura, Executive Officer Shin Gohda, Executive Officer Toshiki Nishino, Executive Officer |
|
Hirohisa Otsuka, Auditor Masaichi Nomura, Auditor (licensed certified public accountant) |
|
Senior Advisor | Teruhiro Arakawa |
Establishment | March 14, 1972 |
Capital investment | 100,000,000 JPY |
Employees | 154 (Including the number of employees of Nard Chemicals, LTD.) (as of April, 2024) |
Technical Advisers | Hiroshi Akimoto, PhD (pharmacology). Formerly, executive managing director, Takeda Pharmaceutical Co., Ltd. |
Group company | About NARD Chemicals |
Corporate History
1972 |
|
---|---|
|
|
1975 |
|
1987 |
|
1989 |
|
1995 |
|
1997 |
|
1998 |
|
1999 |
|
2000 |
|
2007 |
|
|
|
2012 |
|
2014 |
|
2018 |
|
2022 |
|
Patent applications as of the end of December 2023: 202 (Refer to J-PlatPat for details)
Revenue: 4,300,000,000 JPY (FY 2023)